Vanguard reports 7.99M Indivior shares (6.55%)

Indivior Pharmaceuticals Inc ownership reported by Vanguard Portfolio Management LLC: 7,994,836 shares, representing 6.55% of common stock as of 03/31/2026.

Rhea-AI Filing Summary

Indivior Pharmaceuticals Inc ownership reported by Vanguard Portfolio Management LLC: 7,994,836 shares, representing 6.55% of common stock as of 03/31/2026. The filing states Vanguard has sole dispositive power over 7,994,836 shares and sole voting power for 103,017 shares.

The filing notes these holdings include securities held for Vanguard funds and managed accounts and is signed by Ashley Grim on 04/28/2026.

Insights

Institutional Ownership Analyst

Vanguard holds a sizeable passive stake in Indivior (6.55%), consistent with fund-manager portfolio positions.

Vanguard Portfolio Management LLC reports 7,994,836 shares beneficially owned with sole dispositive power over the full amount and sole voting power over 103,017 shares as of 03/31/2026. The filing is a standard Schedule 13G disclosure showing passive institutional ownership.

Implications depend on Vanguard's voting and disposition decisions; the filing states holdings include securities held for Vanguard funds and managed accounts. Subsequent filings may show changes in percent ownership or voting power.

Key Figures

Shares beneficially owned: 7,994,836 shares Percent of class: 6.55% Sole voting power: 103,017 shares +2 more

5 metrics

Shares beneficially owned 7,994,836 shares Amount beneficially owned reported as of 03/31/2026

Percent of class 6.55% Percent of common stock reported in Schedule 13G

Sole voting power 103,017 shares Number of shares with sole power to vote

Sole dispositive power 7,994,836 shares Number of shares with sole power to dispose

CUSIP 45579U109 Identifies Indivior common stock class

Key Terms

Schedule 13G, beneficially owned, sole dispositive power, Investment Company Act of 1940, +1 more

5 terms

Schedule 13G regulatory

"This filing is identified as a Schedule 13G passive ownership statement"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: 7994836 (b) Percent of class: 6.55 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 7994836"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Investment Company Act of 1940 regulatory

"A listing of the shareholders of an investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

CUSIP technical

"CUSIP Number(s): 45579U109"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Indivior (INDV) shares does Vanguard Portfolio Management report owning?

Vanguard reports beneficial ownership of 7,994,836 shares. This equals 6.55% of common stock as stated for the period ending 03/31/2026, and reflects holdings across Vanguard funds and managed accounts.

What voting and disposition powers does Vanguard have over INDV shares?

Vanguard reports sole dispositive power over 7,994,836 shares and sole voting power over 103,017 shares. The filing attributes dispositive authority to Vanguard Portfolio Management LLC and affiliates.

Is Vanguard reporting these INDV shares as passive holdings on Schedule 13G?

Yes. The filing is a Schedule 13G disclosure, used for passive institutional investors, and states holdings are exercised on behalf of Vanguard funds and managed accounts rather than for activist intent.

What date does the file use for the ownership calculation for INDV?

The ownership figure is reported as of 03/31/2026. The signature date on the filing is 04/28/2026, which certifies the reporting information.

Does the filing identify any other person with more than 5% beneficial interest in INDV holdings?

The filing states no other single person's interest exceeds 5%. It explains shares include positions held by Vanguard funds and managed accounts without naming other >5% holders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/28/2026 - 02:06 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Indivior Pharmaceuticals Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

45579U109

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 45579U109

1

Names of Reporting Persons

Vanguard Portfolio Management

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 103,017.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,994,836.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,994,836.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.55 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Portfolio Management LLC and the following affiliates of Vanguard Portfolio Management LLC or business divisions of such affiliates: Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Portfolio Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Portfolio Management LLC, or business divisions of such subsidiaries whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Indivior Pharmaceuticals Inc
(b)	Address of issuer's principal executive offices: 10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD, VA, 23235
Item 2.
(a)	Name of person filing: Vanguard Portfolio Management
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 45579U109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 7994836
(b)	Percent of class: 6.55 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 103017
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 7994836
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Vanguard Portfolio Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vanguard Portfolio Management

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	04/28/2026